Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis

BACKGROUND: Primaquine is the only licensed antimalarial for the radical cure of Plasmodium vivax infections. Many countries, however, do not administer primaquine due to fear of hemolysis in those with glucose-6-phosphate dehydrogenase (G6PD) deficiency. In other settings, primaquine is given witho...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Devine, A, Parmiter, M, Chu, C, Bancone, G, Nosten, F, Price, R, Lubell, Y, Yeung, S
Formatua: Journal article
Hizkuntza:English
Argitaratua: Public Library of Science 2017

Antzeko izenburuak